CD44 and cancer: Qin and coworkers developed an HA-modified pH-responsive nanocarrier via the electrostatic adsorption of HA on the positively charged HB-polymer nanoparticle surface and used it for targeted delivery to CD44-overexpressed cancer cells [105].